Compassionate drug use: an imperative challenge for Bulgarian health system during COVID-19

• The health care system in Bulgaria faces unprecedented challenges trying to take control over the pandemic of COVID-19. • The existing national regulation in Bulgaria leads to delayed and difficult access to investigational drugs via compassionate use programs. • The COVID-19 pandemic will initiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dzhafer, Nigyar, Papathanasiou, Jannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fellowship of Postgraduate Medicine. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239779/
https://www.ncbi.nlm.nih.gov/pubmed/32837882
http://dx.doi.org/10.1016/j.hlpt.2020.05.001
Descripción
Sumario:• The health care system in Bulgaria faces unprecedented challenges trying to take control over the pandemic of COVID-19. • The existing national regulation in Bulgaria leads to delayed and difficult access to investigational drugs via compassionate use programs. • The COVID-19 pandemic will initiate a dialogue among health policy makers and BDA for the establishment of new health policy and clear national regulation due to higher demand for investigational drugs.

Ejemplares similares